SomaGenics, an RNA-focused biotechnology company, expands its IP protection with three newly issued patents by the United States Patent and Trademark Office covering two of the Company's core RNA...
Read More »Rubicon Genomics Licenses Commercialization Rights From SomaGenics for Its RealSeq®-AC Technology for Small RNA-Seq
SANTA CRUZ, Calif., July 28, 2016 /PRNewswire/ — SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing small RNAs, including micro-RNAs and small fragments of ...
Read More »